Recently, the efficacy of anti-VEGF monotherapies such as bevacizumab (Avastin, Genentech Inc.), ranibizumab, and aflibercept, in patients with SMHs associated with AMD has been reported11,16. Here, VEGFA is linked to age-related macular degeneration.